A non-genetic engineering platform for rapidly generating and expanding cancer-specific armed T cells.

Yi-Jou ChenMichael ChenTian-Lu ChengYi-Shan TsaiChang-Hung WangChe-Yi ChenTung-Yun WuShey-Cherng TzouKai-Hung WangJing-Jy ChengAn-Pei KaoShyr-Yi LinKuo-Hsiang Chuang

Published in: Journal of biomedical science (2023)

Collectively, the BsAb-armed T cell technology represents a simple, time-saving, and highly safe method to generate highly pure cancer-specific effector T cells, thereby providing an affordable T cell immunotherapy to patients.

Keyphrases

papillary thyroid
end stage renal disease
squamous cell
newly diagnosed
ejection fraction
peritoneal dialysis
lymph node metastasis
genome wide
high throughput
gene expression
regulatory t cells
immune response
patient reported outcomes
patient reported